Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Syndrome as a Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

NCT05477394 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05477394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05477394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Syndrome as a Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
January 30, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19